ARCHIVES

FDA News: FDA Eases Two-Trial Standard For Proof Of Drug Efficacy

This article is from The Cancer Letter archive.

Vol. 23 No. 11 | March 21, 1997

Download PDF Visit The Full Archive

Related Articles

In Brief: Gigliotti Named Greenwald Special Assistant; Coltman To Get ACCC Clinical Research Award

August 26, 1988

Arsenic Compound Improves Survival Of Adults With APL

February 23, 2007

CPRIT Awards $107.2 Million Round of Grants

September 5, 2014

GlaxoSmithKline Partners With MD Anderson, Fred Hutchinson

December 14, 2012

Coffin, McIntosh Named Cancer Society Research Professors

February 11, 1994

NCI to Press FDA For Quicker Drug Approval, Relaxation Of Survival Impact Requirement

June 26, 1987